VIATRIS INC. Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities
VIATRIS INC. (VTRS) reported Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities of $19.10 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities · last filed 2026-02-26
- VIATRIS INC. unrecognized tax benefits, decrease resulting from settlements with taxing authorities for fiscal 2025 was $19.10M, a 22.44% increase from fiscal 2024.
- VIATRIS INC. unrecognized tax benefits, decrease resulting from settlements with taxing authorities for fiscal 2024 was $15.60M, a 642.86% increase from fiscal 2023.
- VIATRIS INC. unrecognized tax benefits, decrease resulting from settlements with taxing authorities for fiscal 2023 was $2.10M, a 425.00% increase from fiscal 2022.
- VIATRIS INC. unrecognized tax benefits, decrease resulting from settlements with taxing authorities for fiscal 2022 was $400.00K, a 99.15% decline from fiscal 2021.
| Period end | Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities 12 month | Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities 12 month as first filed |
|---|---|---|
| 2025-12-31 | $19.10M 10-K · filed 2026-02-26 | |
| 2024-12-31 | $15.60M 10-K · filed 2026-02-26 | |
| 2023-12-31 | $2.10M 10-K · filed 2026-02-26 | |
| 2022-12-31 | $400.00K 10-K · filed 2025-02-27 | |
| 2021-12-31 | $47.30M 10-K · filed 2024-02-28 | |
| 2020-12-31 | $47.30M 10-K · filed 2023-02-27 | $8.90M 10-K · filed 2021-03-01 |
| 2019-12-31 | $8.90M 10-K · filed 2022-02-28 | |
| 2018-12-31 | $8.90M 10-K · filed 2023-02-27 | $112.50M 10-K · filed 2021-03-01 |
| 2017-12-31 | $112.50M 10-K · filed 2022-02-28 | |
| 2016-12-31 | $32.90M 10-K · filed 2021-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |